Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 11.7044.2126.9216.5114.42

What is the latest Price to Cash Earnings (PCE) ratio of NATCO PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of NATCO PHARMA is 11.70 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202311.70
Mar202244.21
Mar202126.92
Mar202016.51
Mar201914.42

How is Price to Cash Earnings (PCE) of NATCO PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 11.7
-73.54
Mar2022 44.21
64.23
Mar2021 26.92
63.05
Mar2020 16.51
14.49
Mar2019 14.42 -

Other Financial Ratios of NATCO PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,277.2 Cr 2.1% 2.1% 65.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.1%

2.1%

65.5%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses